It is an inhibitory receptor on NK and T cells that binds to HLA-E on target cells, suppressing NK cell activation and contributing to immune evasion in cancer.103 Tumor cells often exploit the NKG2A-HLA-E axis to escape immune detection. The gene discussed is KLRC1; the disease is neoplasm.